Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Baseline values of circulating nucleosomes in Lung Cancer: NUCLEO-LUNG study

Friday, March 22, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The NUCLEO-LUNG study presented baseline values of circulating nucleosomes in lung cancer at ELCC 2024. This research aims to enhance the prognostic capabilities of cancer tests, particularly the Nu.Q® test. The findings may offer valuable insights into lung cancer biomarkers and their clinical applications.
Price reaction · baseline $14.6 (2024-03-21 close) · hit pre-market · 4 other VNRX headline(s) in the window, move may be shared
day 0 close
+0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation of new baseline values for circulating nucleosomes.
  • Potential implications for lung cancer prognosis.
  • Contribution to the understanding of cancer biomarkers.

Full Press Release Details

Poster titled: Baseline values of circulating nucleosomes in Lung Cancer: NUCLEO-LUNG study
Presented at: ELCC 2024
Couraud et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the NUCLEO-LUNG study about?

The NUCLEO-LUNG study presents baseline values of circulating nucleosomes in lung cancer.

Where was the NUCLEO-LUNG study presented?

The study was presented at the ELCC 2024 conference.

What is the significance of circulating nucleosomes?

Circulating nucleosomes may serve as important biomarkers for lung cancer prognosis.

What cancer test is related to the NUCLEO-LUNG study?

The study is related to the Nu.Q® cancer test, which assesses prognostic values.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare NUCLEO-LUNG lung cancer circulating nucleosomes Nu.Q® test biomarkers
Last updated: Mar 22, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk